kidney issues with tirzepatide Parameters in Obesity... : Journal of the American Society of Nephrology 🥇 Tirzepatide and Kidneys: Risks

Facial volume loss is the same fat loss appearing earlier in older or leaner faces

10.1038/379069a0 121 VahlT

No one would expect blood pressure or blood sugar levels to remain just as controlled if someone stopped their medication for those conditions. Makers of these GLP-1 agonists freely agree that people will regain lost pounds if they stop taking the medications, as clinical trial participants did after the trials ended

Under continuous stimulation of IGF-1, IGF-1R/MAPK/PI3K signaling is activated, leading to resistance to estrogen tamoxifen and fluvestrant

Our Greens & Fruits Powder is a powerhouse blend of real whole-food fruits and vegetables, digestive enzymes, probiotics, and fiber

Improvement of glycaemic control and treatment satisfaction by switching from liraglutide or dulaglutide to subcutaneous semaglutide in patients with type 2 diabetes: A multicentre, prospective, randomized, open-label, parallel-group comparison study (SWITCH-SEMA 1 study)